
Dural Arteriovenous Fistula (DAVF) Embolization is a specialized endovascular procedure used to close abnormal connections (fistulas) between the dural arteries and the venous system surrounding the brain or spinal cord. Unlike congenital malformations, DAVFs are typically acquired later in life due to factors such as trauma, blood clots (sinus thrombosis), or infections. The procedure uses a catheter-based approach to navigate the vascular system and "plug" the high-pressure leak into the veins.
Cortical Venous Reflux: A high-risk condition where blood flows backward into the brain's veins, significantly increasing the risk of a life-threatening hemorrhage or stroke.
Pulsatile Tinnitus: A debilitating "whooshing" or rhythmic thumping sound in the ear that matches your heartbeat, caused by high-pressure blood flow near the ear structures.
Increased Intracranial Pressure: When the fistula interferes with normal drainage, causing severe headaches, nausea, or progressive vision loss.
Neurological Deficits: Sudden or progressive weakness, numbness, or seizures caused by "venous congestion" in the brain or spinal cord.
Aggressive Lesion Grading: If diagnostic imaging (Borden or Cognard classification) identifies the fistula as high-grade with a significant risk of bleeding.
Access: A thin, flexible catheter is inserted into a blood vessel in the groin or wrist and threaded toward the brain using real-time X-ray guidance (fluoroscopy).
Anesthesia: The procedure is typically performed under general anesthesia to ensure the patient remains perfectly still, taking approximately 2 to 4 hours.
Transarterial Route: The most common approach, reaching the fistula through the feeding dural arteries (such as the middle meningeal artery).
Transvenous Route: An alternative or combined approach accessing the site through the venous sinuses, which is often highly effective for specific high-grade lesions.
Embolization: Once the catheter is at the target, "embolic agents" are injected to permanently seal the connection. Common agents include:
Liquid Embolics (Onyx or PHIL): Non-adhesive liquids that harden upon contact with blood to fill the fistula "nest."
Microcoils: Small platinum coils that trigger the body's natural clotting process.
Medical Glue (NBCA): A fast-acting adhesive used to instantly seal high-flow connections.
Digital Subtraction Angiography (DSA): The "gold standard" diagnostic test to map the complex architecture of the fistula and its feeding vessels.
Neurological Assessment: A detailed baseline exam of your vision, motor function, and cranial nerves.
Kidney Function Tests: To ensure your kidneys can safely process the contrast dye used during the X-ray guidance.
Fasting: Following "nothing by mouth" instructions for 8 hours prior to the administration of anesthesia.
Medication Audit: You may be asked to stop taking blood thinners several days before the procedure to minimize the risk of bleeding at the access site.
MRI or CT Angiography: To visualize the relationship between the fistula, the dural sinuses, and the surrounding brain tissue.
Formal Hearing Test: Often required for patients presenting with pulsatile tinnitus to establish a baseline.
Blood Panels: A routine check of your blood count and clotting factors to ensure a safe endovascular experience.
ECG: A standard heart check to confirm cardiovascular stability for the duration of the procedure.
Hospital Stay: Patients are typically monitored in the hospital for 1 to 2 days to ensure there are no changes in neurological status.
Immediate Symptoms: It is normal to experience mild headaches and soreness at the puncture site (groin or wrist) for 2–3 days.
Activity Restrictions: No heavy lifting (over 4.5 kg / 10 lbs) or strenuous exercise for 5 days following the procedure to allow the access site to heal.
Follow-up Imaging: A repeat angiography is usually performed at 6 and 12 months to ensure the fistula remains completely closed.
Symptom Resolution: Most patients notice an immediate disappearance of pulsatile tinnitus and a gradual reduction in headaches as the venous pressure normalizes.
Minimally Invasive: Treating complex brain vascular connections through a tiny puncture in the wrist or groin avoids the risks and recovery time of a craniotomy.
High Success Rates: Modern embolic agents allow for complete occlusion of the fistula in 72% to 90% of cases in a single session.
Targeted Pressure Relief: By closing the fistula, the procedure immediately stops the dangerous backward flow of blood into the brain's delicate veins.
Preserves Normal Flow: Advanced micro-catheters allow specialists to seal the abnormal connection while carefully preserving the healthy blood flow necessary for brain function.
Prevents Future Stroke: Definitive closure of high-risk fistulas provides a durable defense against intracranial hemorrhage and long-term neurological damage.